Baseline Neutrophil-to-Eosinophil Ratio Is Associated with Outcomes in Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors.
Tony Zibo ZhuangDeepak RavindranathanYuan LiuDylan J MartiniJacqueline T BrownBassel NazhaGreta RusslerLauren B YantorniSarah CaulfieldBradley C CarthonOmer KucukViraj A MasterMehmet Asim BilenPublished in: The oncologist (2022)
We conclude that elevated baseline NER may be associated with worse clinical outcomes in mRCC. Although results require further validation, NER is a feasible biomarker in patients with CPI-treated mRCC.